Literature DB >> 22831812

What is the optimal time for delivery in women with gestational hypertension?

Meredith O Cruz1, Weihua Gao, Judith U Hibbard.   

Abstract

OBJECTIVE: To assess the optimal timing of delivery for women with gestational hypertension. STUDY
DESIGN: A multicenter database that contained 228,668 deliveries was used to extract data on gravidas with gestational hypertension. The week-specific rates of maternal and neonatal morbidity/mortality were calculated after induction of labor. Point wise 95% confidence intervals were calculated around each of these gestational age-specific rates.
RESULTS: After induction of labor, the rate of maternal morbidity/mortality reached a nadir of 89.9 per 1000 live births (95% confidence interval, 68.1-111.8) at 38-38 6/7 weeks' gestation, although the rate of neonatal morbidity/mortality fell to 10.5 per 1000 live births (95% confidence interval, 2.8-18.2) at 39-39 6/7 weeks. There were only 3 total stillbirths in our study cohort.
CONCLUSION: In women with gestational hypertension, induction of labor between 38- and 39-weeks' balances the lowest maternal and neonatal morbidity/mortality.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22831812     DOI: 10.1016/j.ajog.2012.06.009

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Vitamin D status and hypertensive disorders in pregnancy.

Authors:  Heather H Burris; Sheryl L Rifas-Shiman; Susanna Y Huh; Ken Kleinman; Augusto A Litonjua; Emily Oken; Janet W Rich-Edwards; Carlos A Camargo; Matthew W Gillman
Journal:  Ann Epidemiol       Date:  2014-02-15       Impact factor: 3.797

2.  Effect of the timing of delivery on perinatal outcomes at gestational hypertension.

Authors:  Tuncay Yuce; Müge Keskin; Mehmet Murat Seval; Feride Söylemez
Journal:  Interv Med Appl Sci       Date:  2015-06-11

3.  Hypertension in pregnancy and adverse outcomes among low-risk nulliparous women expectantly managed at or after 39 weeks: a secondary analysis of a randomised controlled trial.

Authors:  Michal Fishel Bartal; Ashish Premkumar; Madeline Murguia Rice; Uma M Reddy; Alan T N Tita; Robert M Silver; Yasser Y El-Sayed; Ronald J Wapner; Dwight J Rouse; George R Saade; John M Thorp; Maged M Costantine; Edward K Chien; Brian M Casey; Sindhu K Srinivas; Geeta K Swamy; Hyagriv N Simhan
Journal:  BJOG       Date:  2022-01-06       Impact factor: 7.331

4.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

5.  Labour induction with gestational hypertension: A great obstetric challenge.

Authors:  Meharun-Nissa Khaskheli; Shahla Baloch; Aneela Sheeba; Sarmad Baloch; Fahad Khan
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

6.  Hypertensive Disorders in Pregnant Women Receiving Fertility Treatments.

Authors:  Maryam Barekat; Shahnaz Ahmadi
Journal:  Int J Fertil Steril       Date:  2018-01-07

7.  A systematic scoping review of clinical indications for induction of labour.

Authors:  Dominiek Coates; Angela Makris; Christine Catling; Amanda Henry; Vanessa Scarf; Nicole Watts; Deborah Fox; Purshaiyna Thirukumar; Vincent Wong; Hamish Russell; Caroline Homer
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.